Abstract
Protein kinases are potential targets of drugs to treat many human diseases. Intensive efforts have been made to develop protein kinase inhibitors, but a major challenge is achieving specificity. Exploiting regulatory elements outside the ATP binding pocket, such as the substrate binding site, may provide an alternative that allows generation of competitive inhibitors with improved selectivity. Indepth understanding of substrate recognition by protein kinase is essential for design and refinement of competitive inhibitors. Here we described strategies for specifically targeting protein kinases and highlight our current progress in the development of substrate competitive inhibitors for glycogen synthase kinase-3 (GSK-3).
Keywords: Protein kinase, GSK-3, substrate recognition, inhibitor design, substrate binding site, competitive inhibitors, selectivity, phosphorylation, Synthetic peptides, long-term treatment
Current Pharmaceutical Design
Title:Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases
Volume: 18 Issue: 20
Author(s): Avital Licht-Murava and Hagit Eldar-Finkelman
Affiliation:
Keywords: Protein kinase, GSK-3, substrate recognition, inhibitor design, substrate binding site, competitive inhibitors, selectivity, phosphorylation, Synthetic peptides, long-term treatment
Abstract: Protein kinases are potential targets of drugs to treat many human diseases. Intensive efforts have been made to develop protein kinase inhibitors, but a major challenge is achieving specificity. Exploiting regulatory elements outside the ATP binding pocket, such as the substrate binding site, may provide an alternative that allows generation of competitive inhibitors with improved selectivity. Indepth understanding of substrate recognition by protein kinase is essential for design and refinement of competitive inhibitors. Here we described strategies for specifically targeting protein kinases and highlight our current progress in the development of substrate competitive inhibitors for glycogen synthase kinase-3 (GSK-3).
Export Options
About this article
Cite this article as:
Licht-Murava Avital and Eldar-Finkelman Hagit, Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases, Current Pharmaceutical Design 2012; 18 (20) . https://dx.doi.org/10.2174/138161212800672741
DOI https://dx.doi.org/10.2174/138161212800672741 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Stem Cell-Derived Microvesicles: A Cell Free Therapy Approach to the Regenerative Medicine
Current Biotechnology New Insights in Drug-Induced Mitochondrial Toxicity
Current Pharmaceutical Design Synthesis and Pharmacological Profile of an Orally-Active Growth Hormone Secretagogue, SM-130686
Combinatorial Chemistry & High Throughput Screening Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Research Advancements in Porcine Derived Mesenchymal Stem Cells
Current Stem Cell Research & Therapy The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Stem Cell Research & Therapy Systems Biology and Biomechanical Model of Heart Failure
Current Cardiology Reviews Gene Therapy Approaches to Ataxias
Current Gene Therapy Biomarkers in Acute Heart Failure Syndromes: An Update
Current Cardiology Reviews Monitoring Cardiac Function During Idebenone Therapy in Friedreich's Ataxia
Current Pharmaceutical Design Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
Current Cancer Therapy Reviews Antidiabetic Potential of Naturally Occurring Sesquiterpenes: A Review
Current Topics in Medicinal Chemistry A Systematic Review on Levosimendan in Paediatric Patients
Current Vascular Pharmacology High Fidelity SNP Genotyping Using Sequence-Specific Primer Elongation and Fluorescence Correlation Spectroscopy
Current Pharmaceutical Biotechnology The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease
Reviews on Recent Clinical Trials Material-Based Engineering Strategies for Cardiac Regeneration
Current Pharmaceutical Design Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry